Respiratory Tract Infections

They are caused by microorganisms infecting the respiratory tract, with respiratory viruses specifically highlighted in the supplied literature. The grounding also points to respiratory syncytial virus and other respiratory viruses as important aetiologies of lower respiratory infection, and notes that bacterial and fungal kingdoms are also part of the broader respiratory microbiology context.

The disease process begins with invasion of the respiratory system by microorganisms, followed by local pathological changes that can extend from the upper to the lower respiratory tract. The supplied reviews indicate involvement of mucosal immunity, adaptive immunity, homeostasis, microbiota, and inter-kingdom host-microbe interactions, with disease severity influenced by how these systems respond to infection. In vulnerable populations, respiratory viruses can progress to more severe lower respiratory disease such as pneumonia and can contribute to respiratory distress syndromes.

Vulnerability is increased in newborns, infants, the elderly, and immunocompromised individuals. The grounding also indicates that seasonality is relevant, and that transmission dynamics and host-microbiota or immune-state factors can influence disease occurrence and evolution.

The supplied grounding supports prevention and control as a major management domain, but does not provide specific treatment modalities for respiratory tract infections as a whole. It also indicates that diagnosis and pathogen-specific attribution are important, especially for lower respiratory infections and respiratory viruses, but does not support a general drug-class treatment statement for the entire disease category.